EE43 Health Care Resource Utilization (HCRU) and Costs of First-Line Systemic Therapy (1LT) for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (a/mNSCLC) - A Secondary Analysis of Claims Data from the United States (US)
Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.349
https://www.valueinhealthjournal.com/article/S1098-3015(23)00449-7/fulltext
Section Title :
Section Order :
11736
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00449-7&doi=10.1016/j.jval.2023.03.349